LAGUNA HILLS, Calif., Dec. 2, 2013 /PRNewswire/ -- Sonendo®, Inc., the developer of a revolutionary technology for the endodontic marketplace, announced today that it will be presenting at the upcoming Piper Jaffray 25th Annual Healthcare Conference on Wednesday, December 4, 2013. The presentation by Bjarne Bergheim, President and Chief Executive Officer will begin at 2:30pm EST.
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform traditional endodontic therapy. In the United States alone, more than 15 million root canal procedures are performed each year. With its 510(k) FDA clearance and the commercialization of its Multisonic Ultracleaning System™ set to launch in 2014, Sonendo aims to improve clinical quality and business economics of current root canal therapy. Sonendo investors include OrbiMed Advisors LLC, Themes Investment Partners, Fjord Ventures, and NeoMed Management. For more information please visit: www.sonendo.com.
This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
SOURCE Sonendo, Inc.